天然来源创新药物

Search documents
运营近半年,南京生物医药分中心已入驻项目31个
Nan Jing Ri Bao· 2025-05-12 02:28
Core Insights - The Nanjing Biomedicine Center is enhancing the transformation of early-stage biomedical projects by providing comprehensive support services for research teams from various universities [1][2][3] Group 1: Project Development and Support - The Nanjing Biomedicine Center has selected 1,123 medical research results and has 31 projects currently residing at the center [1] - The center has established a team of over 140 technical managers to facilitate the connection between technology and market needs, engaging with 68 universities nationwide [2] - The center provides high-end equipment, such as over 40 high-resolution mass spectrometers, which are essential for new drug development [3][4] Group 2: Financial and Resource Support - The center has created a funding support system with a scale of 8.4 billion yuan, including various financial instruments like angel funds and bank loans [5] - Quick loan approvals have been reported, with one project receiving 6 million yuan in just two weeks, showcasing the center's proactive financial support [5] - The center offers a range of services including intellectual property support and rapid customs clearance for research materials, aimed at reducing barriers for project teams [6] Group 3: Innovation and Collaboration - The center acts as a bridge for technology transfer and innovation, helping teams to "move in with their bags" and focus on development [4] - Collaboration with various universities and institutions is emphasized, with the center attracting diverse project teams from across the country [2][4] - The center aims to facilitate the transition of research outcomes from academic settings to commercial applications, promoting a dual-directional engagement between universities and enterprises [6]